With mammalian cell line engineering and flexible cGMP production scale up to 4,000L in single-use bioreactors, Catalent Biologics offers increased flexibility & manufacturing scale to support customer growth. This article features Justin Koepsel, PhD, MBA where he discusses how our Madison facility plays a role in Wisconsin’s biopharmaceutical manufacturing sector. #Wisconsin #biotech https://ow.ly/7pEP50SxU6A https://bit.ly/465qSoO
Crystal Burris’ Post
More Relevant Posts
-
With mammalian cell line engineering and flexible cGMP production scale up to 4,000L in single-use bioreactors, Catalent Biologics offers increased flexibility & manufacturing scale to support customer growth. This article features Justin Koepsel, PhD, MBA where he discusses how our Madison facility plays a role in Wisconsin’s biopharmaceutical manufacturing sector. #Wisconsin #biotech https://ow.ly/7pEP50SxU6A https://dy.si/9mDcBP
To view or add a comment, sign in
-
With mammalian cell line engineering and flexible cGMP production scale up to 4,000L in single-use bioreactors, Catalent Biologics offers increased flexibility & manufacturing scale to support customer growth. This article features Justin Koepsel, PhD, MBA where he discusses how our Madison facility plays a role in Wisconsin’s biopharmaceutical manufacturing sector. #Wisconsin #biotech https://ow.ly/7pEP50SxU6A https://dy.si/FCcof
To view or add a comment, sign in
-
With mammalian cell line engineering and flexible cGMP production scale up to 4,000L in single-use bioreactors, Catalent Biologics offers increased flexibility & manufacturing scale to support customer growth. This article features Justin Koepsel, PhD, MBA where he discusses how our Madison facility plays a role in Wisconsin’s biopharmaceutical manufacturing sector. #Wisconsin #biotech https://ow.ly/7pEP50SxU6A https://dy.si/KtH3L12
To view or add a comment, sign in
-
With mammalian cell line engineering and flexible cGMP production scale up to 4,000L in single-use bioreactors, Catalent Biologics offers increased flexibility & manufacturing scale to support customer growth. This article features Justin Koepsel, PhD, MBA where he discusses how our Madison facility plays a role in Wisconsin’s biopharmaceutical manufacturing sector. #Wisconsin #biotech https://ow.ly/7pEP50SxU6A https://bit.ly/46npfDd
To view or add a comment, sign in
-
With mammalian cell line engineering and flexible cGMP production scale up to 4,000L in single-use bioreactors, Catalent Biologics offers increased flexibility & manufacturing scale to support customer growth. This article features Justin Koepsel, PhD, MBA where he discusses how our Madison facility plays a role in Wisconsin’s biopharmaceutical manufacturing sector. #Wisconsin #biotech https://ow.ly/7pEP50SxU6A https://dy.si/DMnb8m
To view or add a comment, sign in
-
With mammalian cell line engineering and flexible cGMP production scale up to 4,000L in single-use bioreactors, Catalent Biologics offers increased flexibility & manufacturing scale to support customer growth. This article features Justin Koepsel, PhD, MBA where he discusses how our Madison facility plays a role in Wisconsin’s biopharmaceutical manufacturing sector. #Wisconsin #biotech https://ow.ly/7pEP50SxU6A https://bit.ly/462EykF
To view or add a comment, sign in
-
With mammalian cell line engineering and flexible cGMP production scale up to 4,000L in single-use bioreactors, Catalent Biologics offers increased flexibility & manufacturing scale to support customer growth. This article features Justin Koepsel, PhD, MBA where he discusses how our Madison facility plays a role in Wisconsin’s biopharmaceutical manufacturing sector. #Wisconsin #biotech https://ow.ly/7pEP50SxU6A https://bit.ly/4eX88Mm
To view or add a comment, sign in
-
With mammalian cell line engineering and flexible cGMP production scale up to 4,000L in single-use bioreactors, Catalent Biologics offers increased flexibility & manufacturing scale to support customer growth. This article features Justin Koepsel, PhD, MBA where he discusses how our Madison facility plays a role in Wisconsin’s biopharmaceutical manufacturing sector. #Wisconsin #biotech https://ow.ly/7pEP50SxU6A https://bit.ly/3Sasat8
To view or add a comment, sign in
-
With mammalian cell line engineering and flexible cGMP production scale up to 4,000L in single-use bioreactors, Catalent Biologics offers increased flexibility & manufacturing scale to support customer growth. This article features Justin Koepsel, PhD, MBA where he discusses how our Madison facility plays a role in Wisconsin’s biopharmaceutical manufacturing sector. #Wisconsin #biotech https://ow.ly/7pEP50SxU6A https://bit.ly/3SwmCct
To view or add a comment, sign in
-
With mammalian cell line engineering and flexible cGMP production scale up to 4,000L in single-use bioreactors, Catalent Biologics offers increased flexibility & manufacturing scale to support customer growth. This article features Justin Koepsel, PhD, MBA where he discusses how our Madison facility plays a role in Wisconsin’s biopharmaceutical manufacturing sector. #Wisconsin #biotech https://ow.ly/7pEP50SxU6A https://bit.ly/3W5EtrN
To view or add a comment, sign in